Loading

Cannabis Caucus

  • by Justin Strekal, NORML Political Director January 12, 2018

    Representative Barbara Lee

    Representatives Barbara Lee (D-CA) and Don Young (R-AK today filed a resolution, HR 4779, known as The RE.F.E.R. Act, prohibiting the federal government from taking punitive action against those operating in states where the use and distribution of marijuana is legal.

    NORML is pleased to have worked with Rep. Lee’s office in drafting the language of HR 4779, which “protects individuals in states that have laws which permit the use of cannabis” for either medical or recreational purposes. Specifically, HR 4779 bars federal funding for any efforts that seek to “detain, prosecute, sentence, or initiate civil proceedings against an individual, business or property that is involved in the cultivation, distribution, possession, dispensation, or the use of cannabis in accordance with the law or regulation of the state or unit of local government in which the individual is located.”

    “The federal government should respect the will of the voters in states that have voted to decriminalize cannabis. It’s time to stop wasting taxpayer money on the failed War on Drugs,” said Congresswoman Barbara Lee. “I’m proud to introduce the REFER Act, which would prevent the Attorney General and others in the Trump Administration from stifling the budding cannabis industry. If the federal government chooses to interfere in these state matters, it’s up to Congress to prevent this harmful overreach.”

    It also prohibits the federal government from taking any punitive action against a financial institution “solely because the institution provides financial services to an entity” that is involved in state-sanctioned marijuana-related activities.

    Take action today to tell Congress to support HR 4779!

    With the Justice Department having rescinded Obama-era directives limiting the federal government’s involvement in marijuana states, and with the future of the Rohrabacher-Blumenauer amendment uncertain, it is pivotal that you urge your elected officials to act on HR 4779.

  • by Justin Strekal, NORML Political Director January 11, 2018

    Legalize marijuanaThanks to the tens-of-thousands of individuals just like you, Congress seems to be starting to wake up. Right now, today, Republican Representative Tom McClintock and Democratic Representative Jared Polis are circulating a letter in support of their amendment to defund the Department of Justice’s ability to enforce federal prohibition in the states that have reformed their marijuana laws, both for medical and responsible adult-use.

    Today, one in five Americans resides in a jurisdiction where the adult use of cannabis is legal under state statute, and the majority of citizens reside someplace where the medical use of cannabis is legally authorized.

    Click here to tell your member to co-sign the letter NOW

    There has never been as much support in favor of Congressional action. This is because the politicians are finally starting to get the point. The polls don’t lie: outright majorities of Democrats, Republicans and Independents are in favor of full marijuana legalization.

    They want to deliver the letter tomorrow, so it’s crucial that we make our voices heard quickly. Click here to send a message now.

    After you send your letter so it will stay in their official records, click HERE to find your Representatives office number and then call their Washington, DC office.

    Thanks for standing with us, we will keep you posted as this continues to unfold.

  • by Justin Strekal, NORML Political Director November 29, 2017

    Congressman Dana Rohrabacher (R-CA) addresses NORML members in September, 2017

    Today, sixty-six members of Congress representing both Republicans and Democrats sent a letter to Speaker Ryan, Senate Majority Leader McConnell, Leader Pelosi, and Leader Schumer urging them to maintain the federal protections for the 46 states that have implemented some form of medical cannabis programs throughout the country.

    This comes on the same day the Attorney General Jeff Sessions held a press conference to discuss America’s opioid epidemic and made disparaging comments about marijuana.

    “We’re working on that very hard right now,” Sessions said on Wednesday. “We had meetings yesterday and talked about it at some length. It’s my view that the use of marijuana is detrimental and we should not give encouragement in any way to it. And it represents a federal violation which is in the law and is subject to being enforced, and our priorities will have to be focused on all the things and challenges that we face.”

    From Rep. Rohrabacher’s press release:

    Representatives Dana Rohrabacher (CA-48) and Earl Blumenauer (OR-03) spearheaded a letter, signed by 64 other members of the House of Representatives, urging House and Senate leadership to ensure the inclusion of medical marijuana protections in any appropriations bill that funds the government beyond December 8, 2017. The provision, previously known as “Rohrabacher-Farr,” and now “Rohrabacher-Blumenauer,” bars the Department of Justice from using appropriated funds to prosecute individuals who are acting in compliance with their state’s medical marijuana laws. The provision was first signed into law in December 2014 as part of a larger spending package, and has been in force ever since.

    Congressman Earl Blumenauer (D-OR) speaking a NORML Conference

    Reps Rohrabacher and Blumenauer are both co-chairs of the bipartisan Congressional Cannabis Caucus.

    In September, President Donald Trump reached an agreement with Congressional leadership to enact a three-month continuing resolution that maintains present federal spending levels and priorities through December 8, 2017, which included the amendment that was passed in the previous session of Congress.

    Congressional leadership must reauthorize this language as part of the forthcoming budget in order for the provisions to stay in effect. In July, Sen. Patrick Leahy (D-VT) offered identical language before the Senate Appropriations Committee, which approved it. However, House Rules Committee Chair Peter Sessions (R-TX) has refused to allow House members to vote on similar language. The provision will now be considered by House and Senate leadership when the two chambers’ appropriations bills are reconciled.

    It is imperative that the Rohrabacher-Blumenauer amendment remain the law of the land and AG Sessions not be given the green-light to enact a crackdown. Click here to send a message to your federal lawmakers and urge them to speak out about the need to protect the 2 million registered medical marijuana patients throughout the country.

  • by Justin Strekal, NORML Political Director October 12, 2017
    Congressman Earl Blumenauer (D-OR) speaking a NORML Conference

    Congressman Earl Blumenauer (D-OR) speaking at a NORML Conference

    On Wednesday, October 11th, Congressional Cannabis Caucus Co-Chair Earl Blumenauer (D-OR) testified before the House Energy & Commerce Subcommittee on Health on how to deal with the opioid crisis in America.

    In his testimony, the Congressman makes the case for medical cannabis as a safer alternative to highly addictive opioids, especially for our veterans—as well as the need to remove barriers to medical cannabis research.

    It is well documented that medical marijuana access is associated with reduced rates of opioid use and abuse, opioid-related hospitalizations, opioid-related traffic fatalities, and opioid-related overdose deaths.

    Watch the video below and click here to send a message to your elected officials in support of the CARERS Act of 2017 in support of medical marijuana and click here to send a message to the Office of National Drug Control Policy’s Opioid Commission to urge them to include medical marijuana as part of the national strategy to combat the opioid crisis.

  • by Justin Strekal, NORML Political Director October 6, 2017
    Congressman Earl Blumenauer (D-OR)

    Congressman Earl Blumenauer (D-OR)

    Portland, OR: The Cannabis Fund, a PAC created by Representative Earl Blumenauer to support cannabis-friendly candidates, will be hosting its first annual Gala & Awards on October 6th at the Marriott Waterfront in Portland, OR with NORML founder Keith Stroup as the featured speaker.

    “It is an honor to support Rep. Earl Blumenauer and The Cannabis Fund in 2017. I first met the Congressman in 1973, when he was a freshman state legislator in Oregon who helped pass the nation’s first marijuana decriminalization bill, ending the practice of treating marijuana smokers as criminals. It is exciting to see him continuing to lead the charge to legalize the responsible use of marijuana under federal law, co-founding the Cannabis Caucus in Congress, and author HB 1823, the Marijuana Revenue and Regulation Act,” said Keith Stroup, founder of NORML, “NORML is proud to stand with Rep. Earl Blumenauer in his efforts to end marijuana prohibition and establish a regulated market.”

    Congressman Blumenauer’s Cannabis Profile:

    For more than 40 years, Congressman Earl Blumenauer (OR-03) has fought for the reform of our outdated marijuana laws.

    As an Oregon state legislator, Blumenauer supported the Oregon Decriminalization Bill of 1973, which abolished criminal penalties for possession of small amounts of marijuana.

    Elected to the U.S. House of Representatives in 1996, he has championed several legislative efforts to protect medical marijuana patients, allow the federal government to tax and regulate marijuana, and normalize taxes and banking for marijuana businesses in states where it is legal.

    Blumenauer received the National Organization for the Rationalization of Marijuana Laws Award for Outstanding Public Leadership in 2010. In February 2017, Blumenauer launched the bipartisan Congressional Cannabis Caucus.

Page 2 of 41234